17million dollars india russia, page-4

No, you're not talking to yourself, Blokes. And Medic Vision IS a "screaming buy" as you observe.

With, as you say, $17m worth of live quotes for their products outstanding, and the board confident of strong sales in the UK, Australia, China and Asia Pacific THIS calendar year - not to mention now the push into Russia and India - MVH, with a market cap of just $24m is an absolute gem in the biotech sector.

The herd will pick it up soon enough.

Whoever was spitting the dummy (and overhanging the market) in the past week, is apparently done now. Even after they were taken out, there is evidently still a good deal more buying in reserve.

I can't see the price retreating far from here. And when we begin to hear a string of contracts won...